comparemela.com

Latest Breaking News On - Psychiatry conference - Page 1 : comparemela.com

Quarterly Activities and Cashflow Report

ADELAIDE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) Bionomics Limited (Nasdaq: BNOX | ASX: BNO,), (Bionomics or the Company) a clinical-stage.

United statesSouth australiaPalos verdesSpyridon spyros papapetropoulosExchange commissionCredit suisseBionomics limited nasdaqQuarterly cashflowCantor neurologyPsychiatry conferenceBionomic executive chairmanErrol de souzaBroad pipelinePsychiatric indications does not weighGovernance statementKey opinion leader

NeuroSense Announces Third Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United kingdomLoma linda universityUnited statesSan franciscoNiva russekJeremy shefnerJeffrey rosenfeldCharles duncanFerenc tracikShiran zimriNedira salzman frenkelAmyotrophic lateral sclerosis consortiumNeurosense head of the scientific programCompany investigational new drugPrnewswire neurosense therapeutics ltdDrug administration

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing.

United statesSan franciscoRitz carltonPanel timePanel titlePrnewswire mind medicine mindmed incCompany or mindmedMedicine mindmed incCantor fitzgerald neurologyPsychiatry conferenceMind medicine mindmed inc

atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

04.10.2022 - NEW YORK and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) - atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in in the following .

New yorkUnited statesSan franciscoStephen bardinAllan malievskyExchange commissionLife sciencesnv nasdaqLife sciencesLife sciences virtual rd dayOctober investor eventsHost virtual rd dayInaugural healthcare opportunities conferenceRoth inaugural healthcare opportunitiesPsychiatry conferenceCantor fitzgeraldPrivate securities litigation reform act

Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference

ADELAIDE, Australia, Oct. 04, 2022 Bionomics Limited , a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients. | October 4, 2022

United statesSouth australiaSan franciscoKevin gardnerConnor bernsteinBionomics limited nasdaqBionomics or companyMerck co incCorporate developmentBionomics ltdGlobenewswire incPsychiatry conferenceBionomic executive chairmanEmerging broad pipelinePsychiatric indications does not weighSocial anxiety disorder

vimarsana © 2020. All Rights Reserved.